JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.

Jiangsu Jibeier Pharmaceutical Co., Ltd.

688566

CNE100004041

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
26.05 ^CNY	-1.33%		+17.77%	-17.01%

Apr. 25	Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 08	Jibeier Pharmaceutical's Taxane Compound Method Gets Patent; Shares Down 3%	MT

Jiangsu Jibeier Pharmaceutical Co., Ltd.(XSSC:688566) added to S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about Jiangsu Jibeier Pharmaceutical Co., Ltd.

Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Jibeier Pharmaceutical's Taxane Compound Method Gets Patent; Shares Down 3%	Apr. 08	MT
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 25	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd.(XSSC:688566) added to S&P Global BMI Index	23-09-18	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it expects to receive CNY 298.1619 million in funding	23-06-01	CI
Certain A Shares of Jiangsu Jibeier Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-MAY-2023.	23-05-17	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-17	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
JiangsuJibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
JiangsuJibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
JiangsuJibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-19	CI
Yee Hop : Sells 30% Stake in Research Arm to Jiangsu Jibeier	21-10-12	MT
Shenzhen Huahong Marine Biological Medicine Co., Ltd announced that it expects to receive CNY 90 million in funding from Shenzhen BGI Marine Sci & Tech Co.Ltd, JiangsuJibeier Pharmaceutical Co., Ltd.	21-09-01	CI
Jiangsujibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-26	CI
JiangsuJibeier Pharmaceutical Co., Ltd.(SHSE:688566) added to Shanghai Stock Exchange Composite Index	21-05-21	CI
JiangsuJibeier Pharmaceutical Co., Ltd.(SHSE:688566) added to Shanghai Stock Exchange A Share Index	21-05-21	CI
Certain A Shares of JiangsuJibeier Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-MAY-2021.	21-05-17	CI
JiangsuJibeier Pharmaceutical Co., Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Jiangsujibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-27	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Three Quarters of 2020	20-10-27	CI
Jiangsujibeier Pharmaceutical Co., Ltd. Announces Cash Dividend for the First Half of 2020, Payable on October 19, 2020	20-10-10	CI

Chart Jiangsu Jibeier Pharmaceutical Co., Ltd.

Duration

Period

Chart Jiangsu Jibeier Pharmaceutical Co., Ltd.

More charts

Jiangsu Jibeier Pharmaceutical Co Ltd is a company engaged in the research, development, production and sales of drugs. The Company's products are comprised of tablets, capsules and eye drops. The tablet products include Leucogen tablets, Nitrendipine and Atenolol tablets, Aceclofenac Enteric-coated tablets and Asarone tablets. The Company's products are used to improve white blood cells, treat high blood pressure, eye infections and other diseases.

Sector

Pharmaceuticals

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Jiangsu Jibeier Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

26.05

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.	-17.01%	680M
MERCK KGAA	+5.31%	70.44B
KYOWA KIRIN CO. LTD.	+10.97%	8.94B
SK BIOPHARMACEUTICALS CO., LTD.	-16.83%	4.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+43.48%	4.5B
YUHAN CORPORATION	+3.20%	3.85B
INDIVIOR PLC	+18.82%	2.38B
BETTA PHARMACEUTICALS CO., LTD.	-21.36%	2.34B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-29.67%	2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+8.38%	1.96B

Specialty & Advanced Pharmaceuticals